Category: Regulatory/FDA

Peter Pitts Tells Why FDA DDMAC Letter to Bauman Isn't a First Amendment Issue

MM&M Profiles Tom Sullivan, a Forceful Defender of CME

Join the Discussion on Corporate Backing of Medical Research and CME

Help the FDA Make Informed Decisions

Help FDA Create New Internet & Social Media Rule; Join AAAA/Coalition FDASM Working Group

Sen. Grassley Wants An Accounting of Pharmaceutical and Medical Device Company Contributions

Outgoing NJ AG Report Recommends Further Limits to Physician-Industry Relationships

The Coalition Speaks Out on New DTC Research Analysis

FDA Hearing on the Internet and Social Media – Highlights and Commentary